[1]
2022. Formulation Development and Evaluation of Transdermal Patches of Miglitol. Journal of Pharmaceutical Negative Results. 13, 4 (Nov. 2022), 1425–1431. DOI:https://doi.org/10.47750/pnr.2022.13.04.200.